Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
Authors:
- S A AtlasSAS A Atlas
- D B CaseDCD B Case
- J E SealeyJSJ E Sealey
- J H LaraghJLJ H Laragh
- D N McKinstryDMD N McKinstry
- 1 May 1979
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 1 (3) , 274-280
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Determination of Bradykinin in Blood by a Sensitive RadioimmunoassayScandinavian Journal of Clinical and Laboratory Investigation, 1976
- Angiotensin I-converting enzyme of the kidney cortexBiochimica et Biophysica Acta (BBA) - Enzymology, 1974
- Determination of blood kinin levels by radioimmunoassayBiochemical Pharmacology, 1972
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseThe American Journal of Medicine, 1972
- A Study of the Mechanism of Secretion of the Sodium-Retaining Hormone (Aldosterone)12Journal of Clinical Investigation, 1957
- Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den MineralstoffwechselCellular and Molecular Life Sciences, 1953